1. No category

P R I S M E Forum
Pharmaceutical R & D Information Systems Management Executives
PRISME Forum
BUSINESS MEETING
PRISME Forum Chair:
Matteo di Tommaso, Pfizer
November 18-19, 2014
Thousand Oaks, CA, USA
Host: Amgen
Download our PRISME Forum 2014 Meeting Apps:
http://my.yapp.us/PRISME
and
http://my.yapp.us/PRISMETECH
Registration
http://www.surveygizmo.com/s3/1710945/PRISMEfall2014
Meeting Venue
All sessions and networking events will be held at Amgen’s campus located at One Amgen Center Drive,
Thousand Oaks, CA 91320-1799.
Contacts
Program Coordinator: +44.77.68.173.518 / [email protected]
Secretariat: office: +1.224.938.9523 / mobile: +1.312.622.1234 / [email protected]
2
PRISME Forum Business Meeting, November 18-19, 2014, Thousand Oaks, CA, USA
PRISME Forum Business Meeting Steering Committee
Matteo di Tommaso, VP, Research Business
Technology, Pfizer
Matteo Tommaso leads Research
Business Technology for Pfizer
where he is responsible for strategy
and implementation of IT and
informatics ser-vices for Pfizer
Research. At Pfizer, he has led
efforts on cloud solutions for high
performance
computing
(HPC),
systems integration resulting from
mergers and acquisitions, systems separations as a
result of divestitures and IPOs, drug discovery data for
decision making and insight, translational informatics
solutions for patient stratification and integration of
clinical and molecular data, laboratory automation
services, and data center simplification. His efforts in
pre-competitive collaboration have led to opensource
tools for Chemistry eNotebook and biomolecule
discovery and contributions to efforts including
OpenBEL, Pistoia Alliance and tranSMART.
Before joining Pfizer, in 2004, Matteo led the team at
Celera Genomics responsible for building Celera’s
scientific
information
products
and
Applied
Biosystems’ eCommerce solutions. Prior to that he led
the development of the “SeqStore” product line for
Genetics Computer Group, a set of products and
services for pharmaceutical drug discovery.GCG, he
spent 3 years at the European Bioinformatics Institute
(EBI) at the start of the institute in Cambridge,
UK.Matteo began his career in IT, at Warner-Lambert
Parke-Davis, with a degree in Chemistry from Indiana
University, leading the migration and replacement of
pre-clinical information systems to improve data quality
and usability.
Alastair Binnie, VP, Research Informatics &
Automation, Bristol-Myers Squibb
Alastair Binnie is an executive
leader with over 15 years of
experience leading multi-disciplinary
technology
functions
in
pharmaceutical
discovery
and
exploratory clinical research.
In his current role at Bristol-Myers
Squibb as vice president, Research
Informatics and Automation, he leads a diverse
organization responsible for a broad technology
agenda supporting all research functions at BMS,
including planning, delivering and supporting scientific
IT platforms, laboratory automation, instrument
support services, scientific computing infrastructure
and architecture and software engineering.
Simon Roach, Senior Vice-President, R&D IT,
GlaxoSmithKline
Simon Roach has been the Senior
Vice President of Research and
Development IT at GlaxoSmith-Kline
since October 2008.
He previously served GSK as Vice
President of Development and
Commercial Strategy IT.
He joined the group from Coopers & Lybrand where
he served as Senior Manager of Computer Assurance
Services. Roach began his professional career with
NCR as a Consultant from 1986-1989. Roach
attended Aston University where he received his BSc
in Computing Science and MBA.
Errol Sandler, Treasurer/Board Secretary,
PRISME Forum
Errol Sandler, PhD worked in the
information technology industry for
30 years. His career focused on
research
and
development
computing problems in the life
sciences.
Dr. Sandler provided leadership and
technical expertise for R & D
computing in the pharmaceutical industry. Most
recently, he led teams to provide information
technology support at several Pfizer Global research
and development sites in the United States and the
United Kingdom.
Dr. Sandler received his PhD in Physics and
Astronomy in July of 1977 from the University of
Missouri-Columbia.
Susie Stephens, Senior Director, Oncology &
West Coast Business Technology, Pfizer Inc.
Susie Stephens is responsible for
R&D IT for the West Coast for
Pfizer. As such she provides
support for Oncology, Vaccines,
Rinat, San Diego and San
Francisco Centers for Therapeutic
Innovation, and Partner Lines. She
is responsible for strategy and
delivery of IT services, products, and processes to
achieve successful outcomes for R&D.
Susie has cross-disciplinary experience in informatics,
science and business from leading pharmaceutical
and IT companies. Prior to joining Pfizer, Susie was
Head
of
In
Silico
Immunology,
Janssen
Pharmaceutical Research and Development, where
she had overall responsibility for in silico science for
3
the Immunology Therapeutic Area. She has also
worked for Eli Lilly where she was responsible for
Open Innovation for Research IT, Oracle where she
created and guided the implementation of their product
development strategy for the database for the life
sciences, and Sun Microsystems where she was
market segment manager for the life science.
Susie has a PhD in Physiology from the University of
Exeter, UK; post-doctoral experience in Molecular
Biology from the University of Manchester, UK; and is
an alumnus of Harvard Business School.
He has led the efforts for global harmonization of IS/IT
platforms across the Design, Make, Test and Analyse
processes – including Small molecule Screening,
Chemistry Platforms and Bio Asset supply. Most
recently Jason has led components of the FIPNet
(Fully Integrated Pharmaceutical Network) programme
within AZ to virtualize and externalize R&D capabilities.
Externally he represents AZ within the PRISME Forum
and sits on the board of Pistoia. Jason is also a
member of AMIA and has recently spent a short period
of time exploring Clinical Informatics approaches at
Harvard (DCI).
Jason Swift, Director, R&D Information,
AstraZeneca
John Wise, Program Coordinator, PRISME
Forum
Jason has 18 years of experience
in the Pharmaceutical business
working closely with scientists and
clinicians across multiple R&D
domains and business processes.
He has a scientific background
with a PhD in computational
molecular biology (before it was
called Bioinformatics) from Leeds
University in the UK. He has held
a number of Informatics and IS leadership roles in
AstraZeneca from scientific software developer, global
program manager, and head of Scientific Information
Services.
John is the Program Coordinator for PRISME Forum
as well as Executive Director of Pistoia Alliance,
serving as the primary liaison between the project
teams and the operational team
and board. He is committed to
encouraging pharma to use
expert, third-party, cost-effective,
regulatory-compliant,
hosted
information services.
Jason is currently Director Business Delivery, R&D
Information based in Alderley Park UK. In this role he
is responsible for the delivery of a global portfolio of IS
and Informatics projects and services to the preclinical enabling functions (Discovery Sciences, Global
Safety Assessment and Global DMPK) in AstraZeneca.
Previously,
John
has
held
Informatics leadership roles in a
variety of organizations including
the University of London, Sandoz,
ICRF, Roche, Ipsen, and Daiichi Sankyo. In these
roles, John has gained direct hands-on experience
writing analytical software, teaching computation,
delivering IT services, and providing computer-based
services to the discovery, non-clinical development,
clinical development, and regulatory affairs domains of
the
life-science
industry.
PRISME Forum Host
The Steering Committee of the PRISME Forum would like to thank GlaxoSmithKline, for hosting its spring 2014
meeting
PRISME Forum Statement of Compliance
“All meetings, working groups and communications will be open to all Members and any records thereof will be nonconfidential and available for inspection by any Member. The Members acknowledge that discussing any
commercially sensitive topics, including costs, volumes, inventories, sales level methods, channels of distribution,
access to future products, markets, current or future prices, profitability, contract pricing or trading terms is
prohibited. The Members of PRISME will strictly comply with all laws relevant to their activities, including US state
and federal anti-trust laws and European competition laws.”
4
PRISME Forum Business Meeting, November 18-19, 2014, Thousand Oaks, CA, USA
COMPANY UPDATES
One of the key activities of the PRISME Forum meetings is the “Company Updates.” These updates allow members
to identify common key themes from across our companies such as:






industry trends
common business drivers
challenges
IT initiatives
areas of investment, and
opportunity for pre-competitive (non-competitive) collaboration.
Members often include in their company updates the following kinds of information:
1. High-level company overview with emphasis on R&D priorities and key business drivers of R&D IT strategy,
practice and emerging trends
2. R&D IT/Informatics organization overview with emphasis on key IT/informatics areas of focus for strategy,
implementation and process improvement
3. Any useful benchmarking data (e.g. R&D IT/Informatics expenditure as a percentage of the R&D budget, R&D
IT skills portfolio / skills gaps)
4. And most IMPORTANTLY - anything else a member would like to share or get advice on.
It is important to note:
The spirit of company updates is pre- or non-competitive, collaborative and informal, as such no formal minutes for
these discussions are produced or published. The PRISME Forum is very aware of its responsibilities to avoid any
perception of ‘anti-competitive practices’. As such the PRISME Forum conducts all of its activities in conformance
with all international, U.S. federal and state antitrust laws.
BREAK-OUTS
For the company updates, the group will be divided into five groups which will be announced soon.
GROUP 1
Captain:
Alastair Binnie
(BMS)
GROUP 2
Captain:
Matteo di Tommaso
(Pfizer)
GROUP 3
Captain:
Simon Roach
(GSK)
GROUP 4
Captain:
Susie Stephens
(Pfizer)
GROUP 5
Captain:
Jason Swift
(A/Z)
The company updates are presented within these subgroups. Following a 30-minute break, the groups will
reconvene to summarize their key themes and highlights (flipcharts will be provided).
Subsequently, the five groups will return to the meeting room where group captains will showcase the summaries
and facilitate discussion.
5
PROGRAM
All sessions will be held at Amgen’s Thousand Oaks, CA Campus (One Amgen Center Drive,Thousand Oaks, CA 91320-1799).
TUESDAY, November 18, 2014
11:30 – 12:30
Check in and Lunch
12:30 – 12:45
PRISME Forum - Welcome Notes
12:45 – 13:45
SESSION 1: Amgen Presentation
Company Updates—Part I (breakout session)
Members are divided into five groups with the following group captains: Alastair Binnie, Matteo di Tommaso,
Simon Roach, Susie Stephens, and Jason Swift. Company updates are then presented within these groups.
13:45 – 15:00
15:00 – 15:30
15:30 – 16:00
16:00 – 17:30
17:30
19:00
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer
CIO, Amgen
Coffee Break
Company Updates—Part II (breakout session)
Members are divided into five different groups with group captains.
Company updates are then presented within these new groups.
Company Updates—Part III (plenary session)
Group captains work with the group members to prepare readouts for the plenary session.
Matteo di Tommaso, Chair, PRISME Forum;
Wrap Up and Close of Day 1
VP, Research Business Technology, Pfizer
Group Dinner (PRISME Forum members, member substitutes and invited guests only)
WEDNESDAY, November 19, 2014
7:45 – 8:15
Check-in
8:15 – 8:30
Introduction to Day 2
8:30 – 9:30
10:30 – 11:00
Company Updates—Part IV (plenary session)
Readouts
Company Updates—Part V (plenary session)
Identify common themes and hot topics for next Technical
Meeting
Coffee Break
11:00 – 11:15
Officer Election
11:15 – 12:00
Business Meeting
• Review minutes of the last business meeting
• Membership, new member recruitment, membership fees
• New activities (e.g. surveys, webinars, publications)
• Finances
• Confirm venues and dates for spring 2015
• Discuss potential venues & dates for fall 2015
• Review and vote on any motions proposed during the
meeting
9:30 – 10:30
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer
PRISME Forum Members
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer Inc.
Errol Sandler, Treasurer/Board Secretary,
PRISME Forum
John Wise, Program Coordinator, PRISME
Forum
12:00 – 13:00
Networking lunch with afternoon meeting guests
13:00 – 13:45
SESSION 2: R&D IT Benchmarking Results
13:45 – 14:30
14:30 – 15:00
SESSION 3: Discovery / Non-Clinical Development S/W
survey
Coffee Break
15:00 – 16:00
SESSION 4: Transcelerate Biopharma, Inc.
TBA
16:00 – 17:00
SESSION 5: IMI Strategy Governance Group Update
TBA
17:00 – 17:30
Wrap Up
Matteo di Tommaso, Chair, PRISME Forum;
VP, Research Business Technology, Pfizer
18:30
Joint PRISME Forum Business Group + Tech Group Dinner
6
Martin Leach, VP R&D IT, Biogen Idec
Michael Shanler, Research Director, Gartner
John Apathy, VP, R&D Informatics, Celgene
PRISME Forum Business Meeting, November 18-19, 2014, Thousand Oaks, CA, USA